Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lichun Wei

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Annals of Translational Medicine|August 25, 2021
The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapyHua Yang, Ying Zhang, Changhao Liu, et al.
Neuro-Oncology|December 14, 2021
Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastomaJintao Gu, Nan Mu, Bo Jia, et al.
NPJ Digital Medicine|August 5, 2025
Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center studyWeiping Wang, Guang Yang, Yulin Liu, et al.
NPJ Digital Medicine|December 22, 2025
Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center studyWeiping Wang, Guang Yang, Yulin Liu, et al.
Diagnostic Pathology|November 6, 2015
Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapyYang Lv, Ning Wang, Yixiong Liu, et al.
Frontiers in Oncology|December 3, 2021
Chinese Expert Consensus on Iodine<sup>125</sup> Seed Implantation for Recurrent Cervical Cancer in 2021Ping Jiang, Lijuan Zou, Lichun Wei, et al.
Journal of Gynecologic Oncology|January 9, 2026
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trialShuhua Wei, Xiaofan Li, Zi Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2026
Radiomics-guided Automatic Delineation for Clinical Target Volume of Endometrial Cancer: Limited-sample Multi-center StudyAng Qu, Xile Zhang, Yipeng Song, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2025
Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR TrialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Cancer|March 21, 2024
Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real worldKun Zhang, Tiejun Wang, Zi Liu, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Annals of Translational Medicine|August 25, 2021
The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapyHua Yang, Ying Zhang, Changhao Liu, et al.
Neuro-Oncology|December 14, 2021
Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastomaJintao Gu, Nan Mu, Bo Jia, et al.
NPJ Digital Medicine|August 5, 2025
Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center studyWeiping Wang, Guang Yang, Yulin Liu, et al.
NPJ Digital Medicine|December 22, 2025
Author Correction: Multimodal deep learning model for prognostic prediction in cervical cancer receiving definitive radiotherapy: a multi-center studyWeiping Wang, Guang Yang, Yulin Liu, et al.
Diagnostic Pathology|November 6, 2015
Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapyYang Lv, Ning Wang, Yixiong Liu, et al.
Frontiers in Oncology|December 3, 2021
Chinese Expert Consensus on Iodine<sup>125</sup> Seed Implantation for Recurrent Cervical Cancer in 2021Ping Jiang, Lijuan Zou, Lichun Wei, et al.
Journal of Gynecologic Oncology|January 9, 2026
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trialShuhua Wei, Xiaofan Li, Zi Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2026
Radiomics-guided Automatic Delineation for Clinical Target Volume of Endometrial Cancer: Limited-sample Multi-center StudyAng Qu, Xile Zhang, Yipeng Song, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2025
Quality of Life and Functional Outcomes in Patients With Locally Advanced Rectal Cancer Receiving Total Neoadjuvant Therapy Versus Concurrent Chemoradiation Therapy: An Analysis of the STELLAR TrialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Cancer|March 21, 2024
Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real worldKun Zhang, Tiejun Wang, Zi Liu, et al.
Pageof 6